{"name":"Akebia Therapeutics","permalink":"akebia-therapeutics","crunchbase_url":"http://www.crunchbase.com/company/akebia-therapeutics","homepage_url":"http://www.akebia.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":2007,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"","phone_number":"513-618-0931","description":"pharmaceutical company","created_at":"Fri Sep 18 13:12:34 UTC 2009","updated_at":"Tue Jan 10 03:20:16 UTC 2012","overview":"<p>Akebia Therapeutics, Inc., a pharmaceutical company, focuses on treatments for ischemia and improvement of vascular disease. It engages in the clinical development of compounds for the treatment of anemia and ischemia-related disorders. The company offers Omacor for hypertriglyceridemia; and Actonel for osteoporosis. Its products include prolyl hydroxylase enzyme and phosphatase enzyme. Akebia Therapeutics, Inc. was founded in 2007 and is based in Cincinnati, Ohio.</p>","image":{"available_sizes":[[[150,50],"assets/images/resized/0006/0146/60146v1-max-150x150.jpg"],[[240,81],"assets/images/resized/0006/0146/60146v1-max-250x250.jpg"],[[240,81],"assets/images/resized/0006/0146/60146v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$42.1M","funding_rounds":[{"round_code":"a","source_url":"http://onbiovc.com/akebia-therapeutics-inc-series-a-16m/","source_description":"Akebia Therapeutics, Inc.: Series A $16M","raised_amount":16000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":9,"funded_day":15,"investments":[{"company":null,"financial_org":{"name":"Novartis Venture Fund","permalink":"novartis-venture-fund","image":{"available_sizes":[[[150,13],"assets/images/resized/0005/9083/59083v1-max-150x150.jpg"],[[212,19],"assets/images/resized/0005/9083/59083v1-max-250x250.jpg"],[[212,19],"assets/images/resized/0005/9083/59083v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Technology Venture Investors","permalink":"technology-venture-investors","image":{"available_sizes":[[[150,53],"assets/images/resized/0003/0995/30995v1-max-150x150.png"],[[250,88],"assets/images/resized/0003/0995/30995v1-max-250x250.png"],[[254,90],"assets/images/resized/0003/0995/30995v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Triathlon Medical Venture Partners","permalink":"triathlon-medical-venture-partners","image":{"available_sizes":[[[150,12],"assets/images/resized/0004/5663/45663v1-max-150x150.png"],[[250,20],"assets/images/resized/0004/5663/45663v1-max-250x250.png"],[[450,36],"assets/images/resized/0004/5663/45663v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Athenian Venture Partners","permalink":"athenian-venture-partners","image":{"available_sizes":[[[150,59],"assets/images/resized/0003/6232/36232v4-max-150x150.jpg"],[[250,98],"assets/images/resized/0003/6232/36232v4-max-250x250.jpg"],[[450,177],"assets/images/resized/0003/6232/36232v4-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Sigvion Capital","permalink":"sigvion-capital","image":{"available_sizes":[[[150,39],"assets/images/resized/0006/0147/60147v1-max-150x150.jpg"],[[241,64],"assets/images/resized/0006/0147/60147v1-max-250x250.jpg"],[[241,64],"assets/images/resized/0006/0147/60147v1-max-450x450.jpg"]],"attribution":null}},"person":null}]},{"round_code":"b","source_url":"http://www.akebia.com/news/Akebia_Srs_B_Financing.pdf","source_description":"AKEBIA COMPLETES $22M SERIES B FINANCING","raised_amount":22000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":4,"funded_day":26,"investments":[{"company":null,"financial_org":{"name":"Novartis Venture Fund","permalink":"novartis-venture-fund","image":{"available_sizes":[[[150,13],"assets/images/resized/0005/9083/59083v1-max-150x150.jpg"],[[212,19],"assets/images/resized/0005/9083/59083v1-max-250x250.jpg"],[[212,19],"assets/images/resized/0005/9083/59083v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Venture Investors","permalink":"venture-investors","image":{"available_sizes":[[[150,40],"assets/images/resized/0006/2067/62067v1-max-150x150.jpg"],[[217,58],"assets/images/resized/0006/2067/62067v1-max-250x250.jpg"],[[217,58],"assets/images/resized/0006/2067/62067v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Triathlon Medical Venture Partners","permalink":"triathlon-medical-venture-partners","image":{"available_sizes":[[[150,12],"assets/images/resized/0004/5663/45663v1-max-150x150.png"],[[250,20],"assets/images/resized/0004/5663/45663v1-max-250x250.png"],[[450,36],"assets/images/resized/0004/5663/45663v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Kearny Venture Partners","permalink":"kearny-venture-partners","image":{"available_sizes":[[[150,13],"assets/images/resized/0006/0719/60719v1-max-150x150.png"],[[250,22],"assets/images/resized/0006/0719/60719v1-max-250x250.png"],[[450,41],"assets/images/resized/0006/0719/60719v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Athenian Venture Partners","permalink":"athenian-venture-partners","image":{"available_sizes":[[[150,59],"assets/images/resized/0003/6232/36232v4-max-150x150.jpg"],[[250,98],"assets/images/resized/0003/6232/36232v4-max-250x250.jpg"],[[450,177],"assets/images/resized/0003/6232/36232v4-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Sigvion Capital","permalink":"sigvion-capital","image":{"available_sizes":[[[150,39],"assets/images/resized/0006/0147/60147v1-max-150x150.jpg"],[[241,64],"assets/images/resized/0006/0147/60147v1-max-250x250.jpg"],[[241,64],"assets/images/resized/0006/0147/60147v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"AgeChem Venture Fund","permalink":"agechem-venture-fund","image":{"available_sizes":[[[150,27],"assets/images/resized/0006/8086/68086v1-max-150x150.jpg"],[[250,45],"assets/images/resized/0006/8086/68086v1-max-250x250.jpg"],[[343,63],"assets/images/resized/0006/8086/68086v1-max-450x450.jpg"]],"attribution":null}},"person":null}]},{"round_code":"b","source_url":"http://www.finsmes.com/2012/01/akebia-therapeutics-raises-4-1m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Akebia Therapeutics Raises $4.1M in Series B Financing","raised_amount":4100000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":9,"investments":[{"company":null,"financial_org":{"name":"Novartis Bioventures","permalink":"novartis-bioventures","image":{"available_sizes":[[[150,59],"assets/images/resized/0006/1683/61683v1-max-150x150.png"],[[250,98],"assets/images/resized/0006/1683/61683v1-max-250x250.png"],[[380,150],"assets/images/resized/0006/1683/61683v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Venture Investors","permalink":"venture-investors","image":{"available_sizes":[[[150,40],"assets/images/resized/0006/2067/62067v1-max-150x150.jpg"],[[217,58],"assets/images/resized/0006/2067/62067v1-max-250x250.jpg"],[[217,58],"assets/images/resized/0006/2067/62067v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Triathlon Medical Venture Partners","permalink":"triathlon-medical-venture-partners","image":{"available_sizes":[[[150,12],"assets/images/resized/0004/5663/45663v1-max-150x150.png"],[[250,20],"assets/images/resized/0004/5663/45663v1-max-250x250.png"],[[450,36],"assets/images/resized/0004/5663/45663v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Kearny Venture Partners","permalink":"kearny-venture-partners","image":{"available_sizes":[[[150,13],"assets/images/resized/0006/0719/60719v1-max-150x150.png"],[[250,22],"assets/images/resized/0006/0719/60719v1-max-250x250.png"],[[450,41],"assets/images/resized/0006/0719/60719v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Athenian Venture Partners","permalink":"athenian-venture-partners","image":{"available_sizes":[[[150,59],"assets/images/resized/0003/6232/36232v4-max-150x150.jpg"],[[250,98],"assets/images/resized/0003/6232/36232v4-max-250x250.jpg"],[[450,177],"assets/images/resized/0003/6232/36232v4-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Sigvion Capital","permalink":"sigvion-capital","image":{"available_sizes":[[[150,39],"assets/images/resized/0006/0147/60147v1-max-150x150.jpg"],[[241,64],"assets/images/resized/0006/0147/60147v1-max-250x250.jpg"],[[241,64],"assets/images/resized/0006/0147/60147v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"AgeChem Venture Fund","permalink":"agechem-venture-fund","image":{"available_sizes":[[[150,27],"assets/images/resized/0006/8086/68086v1-max-150x150.jpg"],[[250,45],"assets/images/resized/0006/8086/68086v1-max-250x250.jpg"],[[343,63],"assets/images/resized/0006/8086/68086v1-max-450x450.jpg"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"HQ","address1":"10151 Carver Road","address2":"Suite 205","zip_code":"45242","city":"Cincinnati","state_code":"OH","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}